The Effects of Chronological Age on the Chondrogenic Potential of Mesenchymal Stromal Cells: A Systematic Review
International Journal of Molecular Sciences · 23.10.2023 · 24 (20) · 15494
DOI: 10.3390/ijms242015494 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.10.2023. Verfasst von Antonia Vogt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Trauma & Orthopaedic Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, UK. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Evelyn Medical Research Grant, Versus Arthritis (Formerly Arthritis Research UK) through Versus Arthritis Tissue Engineering and Regenerative Therapies Centre.
Abstract (Originalsprache)
Tissue engineering and cell therapy for regenerative medicine have great potential to treat chronic disorders. In musculoskeletal disorders, mesenchymal stromal cells (MSCs) have been identified as a relevant cell type in cell and regenerative strategies due to their multi-lineage potential, although this is likely to be a result of their trophic and immunomodulatory effects on other cells. This PRISMA systematic review aims to assess whether the age of the patient influences the chondrogenic potential of MSCs in regenerative therapy. We identified a total of 3027 studies after performing a search of four databases, including Cochrane, Web of Science, Medline, and PubMed. After applying inclusion and exclusion criteria, a total of 14 papers were identified that were reviewed, assessed, and reported. Cell surface characterization and proliferation, as well as the osteogenic, adipogenic, and chondrogenic differentiation, were investigated as part of the analysis of these studies. Most included studies suggest a clear link between aged donor MSCs and diminished clonogenic and proliferative potential. Our study reveals a heterogeneous and conflicting range of outcomes concerning the chondrogenic, osteogenic, and adipogenic potential of MSCs in relation to age. Further investigations on the in vitro effects of chronological age on the chondrogenic potential of MSCs should follow the outcomes of this systematic review, shedding more light on this complex relationship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Trauma & Orthopaedic Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, UK.
- School of Clinical Medicine, University of Cambridge, Cambridge CB2 2SP, UK.
ORCID-Profile: Konstantinos Kapetanos, Neophytos Christodoulou, Dimitrios Asimakopoulos, Wasim Khan
Förderung
- Evelyn Medical Research Grant
- Versus Arthritis (Formerly Arthritis Research UK) through Versus Arthritis Tissue Engineering and Regenerative Therapies Centre
Zitieren
APA
Vogt, A., Kapetanos, K., Christodoulou, N., Asimakopoulos, D., Birch, M. A., McCaskie, A. W., & Khan, W. (2023). The Effects of Chronological Age on the Chondrogenic Potential of Mesenchymal Stromal Cells: A Systematic Review. International Journal of Molecular Sciences, 24(20), 15494. https://doi.org/10.3390/ijms242015494
Vancouver
Vogt A, Kapetanos K, Christodoulou N, Asimakopoulos D, Birch MA, McCaskie AW, et al. The Effects of Chronological Age on the Chondrogenic Potential of Mesenchymal Stromal Cells: A Systematic Review. International Journal of Molecular Sciences. 2023;24(20):15494. doi:10.3390/ijms242015494
BibTeX
@article{Vogt2023,
author = {Vogt, Antonia and Kapetanos, Konstantinos and Christodoulou, Neophytos and Asimakopoulos, Dimitrios and Birch, Mark A and McCaskie, Andrew W and Khan, Wasim},
title = {The Effects of Chronological Age on the Chondrogenic Potential of Mesenchymal Stromal Cells: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15494},
doi = {10.3390/ijms242015494}
}
EUVIMED